Researchers uncover mutation patterns in childhood mastocytosis
The commonly known KIT D816V mutation appeared only in systemic disease, while other KIT mutations were seen in skin-limited cases.
Megan Garlapow, PhD
Megan Garlapow, PhD, is the principal and owner of The Line Medical Communications, LLC, where she brings extensive experience in medical communications across diverse therapeutic areas. Dr Garlapow earned her BA in biology from the University of Chicago and her PhD in genetics from North Carolina State University. With a strong background in biomedical science and genetics, Dr Garlapow has held key roles in medical education and clinical genetics and genomics, where she honed her skills in developing strategic proposals, securing funding, delivering high-quality educational content, and composing engaging medical journalism pieces.
